1. "Center for Hematologic Malignancies"
Formats
  1. Journal Article (6096)
  2. Meeting Abstract (6017)
  3. Review (387)
  4. Book Section (215)
  5. Editorial (164)
  6. Research Letter (151)
  7. Guidelines (80)
  8. Conference Paper (70)
  9. Correspondence (56)
  10. Miscellaneous (17)
  11. Book Whole (10)
Groups
  1. Center for Hematologic Malignancies (13263)
  2. Department of Medicine (10841)
  3. Hematologic Malignancies, Division of (10394)
  4. GSK Faculty (5359)
  5. Adult Leukemia (3617)
  6. Sloan Kettering Institute Faculty (3339)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (158)
  2. 2024 (575)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3280)
  2. Journal of Clinical Oncology (860)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (303)
  5. Cancer Research (300)
  6. Haematologica (266)

More Publications

Publishers
  1. American Society of Hematology (3541)
  2. Elsevier Inc. (1674)
  3. Nature Publishing Group (1091)
  4. American Society of Clinical Oncology (905)
  5. American Association for Cancer Research (670)
  6. Wiley Blackwell (432)

More Publishers

Results (13263)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiobiological properties of the human hematopoietic microenvironment: Contrasting sensitivities of proliferative capacity and hematopoietic function to in vitro irradiation
    Journal Article

    Laver, J.; Ebell, W.; Castro-Malaspina, H.
    Blood (1986)

    Fulltext@MSK | Save
  • Evaluation of malignant lymphomas using three classifications and the working formulation: 482 cases with median follow-up of 11.9 years
    Journal Article

    Lieberman, P. H.; Filippa, D. A.; Straus, D. J.; Thaler, H. T.; Cirrincione, C.; Clarkson, B. D.
    The American Journal of Medicine (1986)

    Fulltext@MSK | Save
  • Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities
    Journal Article

    Koziner, B.; Myers, J.; Cirrincione, C.; Redman, J.; Cunningham, I.; Caravelli, J.; Nisce, L. Z.; McCormick, B.; Straus, D. J.; Mertelsmann, R.; more...
    The American Journal of Medicine (1986)

    Fulltext@MSK | Save
  • Restoration of normal hematopoiesis in patients with blastic phase chronic myelogenous leukemia (BLCML) treated with mitoxantrone
    Meeting Abstract

    Arlin, Z.; Berman, E.; Jhanwar, S.; Chaganti, R.; Gams, R.; Schoch, I.; Dukart, G.
    Proceedings of the American Association for Cancer Research Annual Meeting (1985)

    Fulltext@MSK | Save
  • Update of autologous stem-cell transplantation (ASCT) for poor prognosis lymphoma
    Meeting Abstract

    Gulati, S.; Shank, B.; Straus, D.; Koziner, B.; Yopp, J.; Black, P.; Fuks, Z.; O'Reilly, R.; Clarkson, B.
    International Journal of Cell Cloning (1985)

    Fulltext@MSK | Save
  • Recent results of multimodal therapy of primary gastric lymphoma
    Meeting Abstract

    Shiu, M. H.; Nisce, L. Z.; Pinna, A.; Straus, D. J.; Tome, M.; Filippa, D. A.; Lee, B. J.
    American Journal of Clinical Oncology (1985)

    Fulltext@MSK | Save
  • Acute leukemia following testicular carcinoma - Reply
    Journal Article

    Redman, J. R.; Vugrin, D.; Arlin, Z. A.; Gee, T. S.; Kempin, S. J.; Godbold, J. H.; Schottenfeld, D.; Clarkson, B. D.; Berman, E.
    Journal of Clinical Oncology (1985)

    Fulltext@MSK | Save
  • Lectin agglutinability of the human hematopoietic stem cell – To the editor
    Journal Article

    Castro-Malaspina, H.; O'reilly, R. J.
    Blood (1985)

    Fulltext@MSK | Save
  • Phase I-II trial of fludarabine phosphate in acute leukemia
    Meeting Abstract

    Warrell Jr, R. P.; Berman, E.; Gee, T. S.; Kempin, S. J.
    Proceedings of the American Association for Cancer Research Annual Meeting (1985)

    Fulltext@MSK | Save
  • Pharmacokinetics of idarubicin (4-DMDR) with or without cytarabine (ARA-C) in patients (pts) with relapsed leukemia
    Meeting Abstract

    Hancock, C.; Niedzwiecki, D.; Merke, D.; Berman, E.; Williams, L.; Bauer, T.; Perri, G.; Young, C.
    Proceedings of the American Association for Cancer Research Annual Meeting (1985)

    Fulltext@MSK | Save